investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
CRC Tier 1 - BAF subunits assembled into functionally specialized complexes in the developing hemopoietic system and in leukemia
Julie Lessard
0 Collaborator(s)
Funding source
Canadian Institutes of Health Research (CIHR)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Tak Mak
CRC Tier 1 - Determining why mutations of the metabolic enzyme isocitrate dehydrogenase cause leukemias and brain cancers
Leukaemia
Peter Aplan
Collaborative Pathways that Lead to Leukemia
Leukaemia
Pathology
Hematology and hematologic malignancies
Peter Aplan
Activation of Proto-Oncogenes by Chromosomal Translocation
Leukaemia
Pathology
Hematology and hematologic malignancies
Aaron David Schimmer
Targeting mitochondrial translation as a novel therapeutic strategy for AML
Leukaemia
Tomasz Skorski
BCR/ABL-PI-3k-ROS pathway induce genomic instability ....
Leukaemia
Pathology
Hematology and hematologic malignancies
Danilo Perrotti
Role of microRNAs in the Regulation of CML Stem Cell Self Renewal and Survival
Leukaemia
Pathology
Hematology and hematologic malignancies
Peter Blumberg
Molecular Mechanism of Action of Phorbol Ester
Leukaemia
Aaron David Schimmer
Targeting the mitochondrial proteasome, ClpP, in AML
Leukaemia
H Leighton Grimes
Developing Novel STAT5 Protein Inhibitors for Treatment of Leukemias
Leukaemia
Pathology
Hematology and hematologic malignancies